Actionable news
0
All posts from Actionable news
Actionable news in IONS: IONIS PHARMACEUTICALS Inc COMMON STOCK,

Leerink Swann Slashes Price Target for Ionis Pharmaceuticals Inc (IONS); Here’s Why

On Wednesday, Ionis Pharmaceuticals Inc (NASDAQ:IONS) hosted an R&D day in NYC, where it framed the antisense/IONS vs RNAi debate particularly as it pertains to the TTR amyloidosis program, and highlighting the outlook for the next-generation lica and Generation 2.5 chemistry.

Following the event, Leerink Swann analyst Michael Schmidt weighed in on the stock, reiterating a Market Perform rating, while slashing the price target to $26 (from $39), which...


More